MedTrace Logo

Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy

NCT06690593 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2990

Last updated 2024-12-27

No results posted yet for this study

Summary

This is an observational case-control study, aiming to systematically analyze the gut microbiome characteristics of patients with monoclonal gammopathy of undetermined significance (MGUS). The study will collect blood and stool samples from MGUS patients, non-MGUS patients (with similar diseases), and healthy controls, and perform multi-omics detection including microbiomics, peptidomics, and biochemical immunology. It will comprehensively analyze the abnormal features of the gut microbiome in MGUS patients, which may help provide new biomarkers and potential mechanisms for the diagnosis, prognosis evaluation, and treatment strategies of MGUS.

Conditions

  • Monoclonal Gammopathy of Undetermined Significance (MGUS)
  • Intestinal Flora
  • Multiple Myeloma
  • M-Protein

Sponsors & Collaborators

  • Zhujiang Hospital

    lead OTHER

Principal Investigators

  • Hongwei Zhou, Professor · Southern Medical University, China

Eligibility

Min Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-26
Primary Completion
2026-06-30
Completion
2026-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06690593 on ClinicalTrials.gov